IVF Hartmann Holding AG operates in the Surgical appliances and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IVF Hartmann Holding AG with three other
medical equipment manufacturers in Europe:
Prim, S.A.
of Spain
(2018
sales of 134.11 million Euro [US$148.35 million]
of which 100%
was Medical/Hospitality),
Medartis Holding AG
(121.32 million Swiss Francs [US$122.18 million]
of which 55%
was EMEA), and
Vitrolife AB
which is
based in Sweden
(1.15 billion Swedish Kronor [US$119.59 million]
of which 53%
was Media).
Sales Analysis.
IVF Hartmann Holding AG reported sales of 133.38 million Swiss Francs (US$134.32 million)
for the
year ending
December of 2018.
This
represents
a very small
increase of 0.3%
versus 2017, when the company's sales were 132.99 million Swiss Francs.
Despite this increase, sales are still
slightly
below the level achieved in 2016, when IVF Hartmann Holding AG
reported sales of 134.69 million Swiss Francs.
The sales level in 2018 was fairly close to the level five years ago: in 2013, IVF Hartmann Holding AG had sales
of 125.43 million Swiss Francs.
Sales of Infections Management saw an increase
that was more than double the company's growth rate: sales were up
6.6% in 2018, from
45.92 million Swiss Francs to 48.95 million Swiss Francs.
Not all segments of IVF Hartmann Holding AG experienced an increase in sales in 2018:
sales of Other Activities fell 14.2% to 14.93 million Swiss Francs.
IVF Hartmann Holding AG also experienced decreases in sales in
Wound Management (down 0.4% to 40.82 million Swiss Francs)
and
Incontinence Management (down 0.0% to 28.68 million Swiss Francs)
.